Neuromuscular (Exam III) Flashcards
1
Q
Multiple Sclerosis pathophys
A
progressive, autoimmune demylelination of central nerve fibers
2
Q
onset of MS
A
20-40
3
Q
risk factors for MS
A
1st degree relative
EBV
other autoimmune disorders
smoking
4
Q
triggers for MS
A
stress
elevated temps
postpartum period
5
Q
s/s of MS
A
motor weakness, sensory disorders, visual impairment, autonomic instability
varies based on site of demyleination
6
Q
treatment for MS
A
no cure
managed by corticosteroids, immune modulators, targeted antibodies
7
Q
pre-anesthetic considerations for MS
A
assess existing deficits
if respiratory compromise - consider PFTs
Labs: CBC with platelets, BMP w/wo LFT
consider preop steroids
temperature management is crucial
avoid succinycholine
8
Q
why might you draw a BMP with LFT on a MS patient
A
on dantrolene and azathioprine - causes bone marrow suppression, liver function impairment
*close attention to glucose and electrolyes as steroids may impact levels
9
Q
what anesthetic plan might you have for a MS patient
A
General, regional, peripheral nerve block are acceptable options
10
Q
what RSI agent would you avoid in MS
A
succinycholine - may induce HyperK+
11
Q
what might hyperthemia do to an MS patient
A
preciptate an exacerbation of MS symptoms
12
Q
when is maysthenia gravis (MG) muscle weakness exacerbated
A
w/ exercise
13
Q
thymic hyperplasia in myasthenia gravis is common at _____% with _____% of patients improving with thymectomy
A
thymic hyperplasia in myasthenia gravis is common at 10% with 90% of patients improving with thymectomy
14
Q
what can cause symptom exacerbation with myasthenia gravis
A
pain, insomnia, infection, surgery
15
Q
treatment of myasthenia gravis
A
ACh-E inhibitors (pyridostigmine), immunosuppressive agents, steroids, plasmapharesis, IVIG
*90% of patients improve with thymectomy
16
Q
MG preanesthetic considerations
A
assess existing deficits
if respiratory compromise, consider PFTs
optimize respiratory function
Labs: CBC, BMP +/- LFT
counsel pt on increased risk of postop vent support until fully recovered from anesthesia
17
Q
4 medication considerations with MG
A
reduce NMB dose to avoid prolonged muscle weakness
caution with opioid to avoid respiratory compromise
ACh-E inhibitors prolong succinycholine and ester LAs (X-caine)
preop steroid with anyone on long term steroids
18
Q
when would you add an LFT to MG chem panel
A
if the patient is on azathiporine
19
Q
eaton-lambert syndrome pathophysiology
A
autoantibodies against VG Ca++Channels
-reduce Ca++ influx decreasing ACh release
20
Q
60% of eaton lambert syndrome cases are associated with what
A
small cell lung carcinoma
21
Q
s/s of Eaton Lamber Syndrome
A
progressive limb-girdle weakness, dysautonomia, oculbulbar palsy
22
Q
treatment for eaton lambert syndrome
A
Selective K+ channel blocker
“3-4 diaminopyridine”
ACh-E inhibitors
Aziathioprine (immunologics)
Steroids
Plasmapheresis, IVIG
23
Q
preanesthetic considerations for ELS (Eaton Lambert Syndrome)
A
assess exsisting deficits
if respiratory compromise - PFTs
optimize respiratory functoin
*extreme caution with NMB and opioid dosing
may need post-op respiratory support until fully recovered from anesthesia
24
Q
ELS and neuromuscular blockers
A
VERY SENSITIVE to ND-NMB and D-NMB
*significantly more sensitive to ND-NMB than MG patients
25
muscular dystophy pathophysiology
hereditary disorder of msucle fiber degerneration caused by breakdown of the **dystophin-glycoprotein complex**
- leading to myonecrosis, fibrosis, and skeletal membrane permeability
26
what is the most common and severe form of muscular dysrophy
who does it affect- onset & lifespan
Duchenne (DMD)
occurs only on boys, onset 2-5y
Wheelchair bound by 8-10 y
lifespan 20-25 d/t cardiopulm complications
27
s/s of muscular dystrophy
progressive skeletal muscle wasting without motor/sensory abnormalities, kyphoscolosis, long bone fragility, respiratory weakness, frequent PNE, EKG changes
28
what lab is elevated in muscular dystrophy and why?
creatine kinase due to muscle wasting
29
what is myotonia
prolonged contractions after muscle stimulation, seen in several muscle disorders
30
most common myotonia
myotonic dystrophy
onset: 20-30 y
muscle wasting in face, masseter, hand, pre-tibial muscles & may effect pharyngeal, laryngeal, diaphragmatic muscles
cardiac conduction may be effected
31
what valvular disorder is seen in myotonic dystrophy
20% have mitral valve prolapse
32
myotnia congenita involves what muscles
skeletal.
smooth and cardiac muscles are spared
(milder form)
33
what is central core disease
rare. core muscles cells lack mitochondrial enzymes
- proximal muscle weakness & scoliosis
34
what triggers myotonias
stress and cold temps
35
treatment for myotonias
no cure
managed with quinine, procainamide, steroids
36
preanesthetic condiserations for muscular dystrophies
CBC, BMP, PFTs, consider CK
preop EKG, ECHO - elvaluate for cardiomyopathy
37
drug condiserations for muscular dystrophies
caution with Non-depolarizing NMB (careful montiroing throughout)
hypermetabolic syndrome - similar to MH seen with sux and volatile anesthetics
life threatrening HyperK+ and arrythmias seen with sux
Sux and VA may exacerbate instability of muscle membrane
38
pre anesthetic considerations for muscular dystrophy (9)
* assess extent of CV and pulmonary abnormalities
* assess breath and heart sounds
* GI hypomotility (aspiration risk)
* high reactio of endocrine abnormalities (check thyroid and glucose levels)
* keep warm to avoid flares
* avoid Depolarizing NMB b/c fasiculations trigger myotonia
* caution with opioids
* optimize respiratory status
* incerased risk of postop respitatory weakness
39
3 major dementia syndromes
alzheimers (70%)
Vascular dementia (25%)
parkinsons (5%)
40
basic preop consierations with dementia patients
assess level of cognitive dysfunction
if patient unable to give informed consent look to medical POA
investigate any advanced directives for medical decision making
basic labs and pertinent test/imaging
potential aspiration risk (may be full stomach)
increased risk for postop delirium
41
which preop meds need to be reviewed prior to anesthetic with dementia patients
ACh-I, MAOIs, psych meds
42
preferred anesthetic plan on dementia patietns
regional - decreased opioid requirement
*balance opioids to meet analgesic requirement without exacerbating delirium
43
parkinson's disease pathophysiology
degeneration of dopaminergic fibers of basal ganglia
unknown case. advanced age is the biggest risk factor
44
dopamine regulates the _________ by ____ _____ stimulation, which is stimulated by _______
dopamine regulates the **extrapyramidal motor system** by **inhibiting exess** stimulation, which is stimulated by **ACh**
45
T/F in parkinsons the motor neurons are under stimulated
false, in parkinon's motor neurons are over stiumulated
46
triad of symptoms with parkinsons
skeletal muscle **t**remor, **r**igitidity, **a**kinesia, **p**osture
TRAP
47
other symptoms of parkinsons
pill roll tremor, facial rigidity, slurred speech, difficulty swallowing, respiratory difficutlty, depression, dementia
48
treatment for parkinsons
Levadopa (cross BBB), anticholinergics, MAOIs (inhibit dopamine degredation), deep brain stimulator
49
preanesthetic considerations for parkinsons
assess severity with special attetention to respiratory compromise
review home meds (MAOIs)
basic labs along with PFT if respiratory symptoms
EKG, ECHO if indicated
increased aspiration risk (dysphagia, or possible dementia)
50
mediations to avoid in parkinsons patients
avoid reglan, phenothiazines, butyrophenones
avoid demerol if on MAOI
51
parkinsons home med to continue prior to surgery
PO levadopa must be continued to avoid unstable extrapyramidal effects such as chest wall rigidity
52
parkinsons patient with Deep brain stimulator considerations
* may need to be disabled to avoid interaction with cautery
* if cautery used, biopolar recommended
53
primary, most common brain tumor
gliomas (~45%)
types based on histologic cell-type
subclasses based on oncogenic mutations
54
benign mengiomas
15%, arise from dura or archnoid tissue
55
pituitary adenomas
7%, noncancerous, majority found on autopsy
56
metastatic carcinoma
6%, can vary widely in origin and symptoms
57
other types of brain tumors
schawnnomas, craniopharyngiomas, dermoid tumors
58
in regards to brain tumors what can cause neurologic deficits
the mass!
increases ICP, papilledema, headache, mental impairment, mobility impairment, vomiting, autonomic dysfunction, seizures
59
brain tumors - pre anesthesia considerations
history, previous therapies, presenting symptoms
radiation damage may lead to lethargy and AMS
chemoteraphy may also have neuro effects
CBC, BMP (glucose), EKG
CT/MRI
preop steroids and antiseizure per surgeon
60
why are patients w brain tumors on steroids
minimize cerebral edema
*continue steroids and monitor glucose
61
what diuretic is used to reduce ICP and pressure
mannitol
62
autonomic dysfunction from brain tumor may manifest on
EKG
labile HR and BP
63
anticonvulsants are common with which lesions
supratentorial lesions
64
cerebrovascular disease preop considerations
* review history, deficits, imaging, treatments, and co-existing disease
* assess orientation, pupils, bilateral grip stregnth, LE strength
* ask about headache, tinnitus, vision/memory loss, bathroom issues
* assess cause of CVA - vascular, embolic
* Imaging- carotid U/S, CT/MRI head and neck and ECHO
* preop EKG
* CBC, BMP (including glucose)
65
causes of embolic CVA
afib, prostethic valve, right to left shunt, PFO
66
new anticoagulant use for cardiac thrombus means what
no elective cases within 3 months
67
if pt is on anticoagulant for CVA prophylaxis
consult prescriber to establish protocol
68
high risk patients on long acting anticoags need what to bridge the gap
short acting anticoagulants (LMWH, IV unfractionated heparin)
*close monitoring of coagulation status is required
69
can you do regional anesthesia on a pt with CVA history and anticoags
if anticoags have been D/Cd for sufficient time to perform block
70
clincal manifestations of regional strokes - anterior cerebral artery
contralateral leg weakness
71
# 1.
clincal manifestations of regional strokes - middle cerebral artery
contralateral hemiparesis and hemisensory deficits (face and arm more than legs)
aphasia (dominant hemisphere)
contralaterral visual defect
72
clincal manifestations of regional strokes - posterior cerebral artery
contralateral visual vield defect
contralateral hemiparesis
73
clincal manifestations of regional strokes - penetrating arteries
contralateral hemiparesis
contralateral hemisensory deficits
74
clincal manifestations of regional strokes - basilar artery
oculomotor deficits and or ataxia with crossed sensory and motor deficits
75
clincal manifestations of regional strokes - veterbal artery
lower cranial nerve deficits and or ataxia with crossed senory deficits
76
majority of aneurysms not diagnosed before _____
rupture
* only 1/3 aneursyms pts have sx before rupture
77
s/s of cerebral aneursym
headache, photophobia, condusion, hemiparesis, coma
78
risk factors for cerebral aneursym
HTN
smoking
female
oral contraceptive
cocaine use
79
diagnosis of cerebral aneursym
CT/angio
MRI
lumbar puncture with CSF analysis (if rupture suspected)
80
intervention for cerebal aneurysm should be preformed within how many hours of rupture for best outcome
72 hours
81
pre-anesthesia considerations for cerebral aneursyms
CT/MRI, EKG, ECHO, CBC, BMP, T&C with blood available
*BP control, mannitol (avoid rupture)
*seizure prophylaxis, CVC*
82
surgical treatment of cerebral aneursyms
coiling, stenting, trapping, bypass (very large aneursyms)
*Neurosurgery on standby incase of intraop rupture/SAH
83
T/F pts with cerebral aneurysms may be on steroids
True, monitor glucose
84
when are vasospasms likely to occur post Sub archonid hemorrage (SAH)
3-15 days post SAH
85
triple H therapy for SAH vasospasm
hypertension
hypervolume
hemodilution
*to avoid complications of hypervolemia, **HTN** is the initial main treatment
86
interventional treatment for post SAH vasospasm
balloon dilation
direct injection of vasodilators to relieve the vasospasm
87
aneursym grading for prognosis
Hunt & Hess
0- unruptured
1- reputrued with minimal headdache and no neuro deficits
2- moderate to sever headache, no deficit other than cranial nerve palsy
3- drowsiness, confusion, mild focal motor deficit
4- stupor, significant hemiparesis, early decebration
5 - deep coma, decebrate rigidity
88
what is an AVM
aterial to venous connection without intervening capillaries
*high flow, low resistance shunting
*believed to be congetinal
89
symtpoms of AVM
range from mass-effects to hemorrhage
90
where are majority of AVM located
supratentorial
91
diagnosis of AVM
angio, MRI
92
treatment of AVM
angio-guided embolization
surgical resection (higher mortality)
93
pre anesthesia considerations for AVM
H&P, review meds, imaging, CBC, BMP, T&C, EKG, ECHO
*BP control, seizure prophalyxsis
*large bore IV access x2, Aline
94
traumatic brain injury "TBI" severity is categorized by
GCS - glasco-coma scale
95
primary injury -TBI
| TBI (traumatic brain injury)
occurs at time of insult
96
intubation is required in severe TBI
GCS <9
AW trauma
respiratory distress
97
mild hyperventilation to control
ICP
98
pre anesthesia considerations for TBI
**do not delay emergent surgery**
review co-morbidities, degree of injury, imaging, labs, gross neuro exam
*C-Spine stabilization, IV access, CVC, ALine, possible uncrossmatched blood if no time for T&C
*intraop ISTAT, pressors, bicarb, Calcium
99
why to refrain from NGT/OGT in TBI
potential basal skull fracture
100
chari malformation
congential displacement of cerellum
C/o Headache, extending to shoulders/arm, visual disturbances, ataxia
Tx= surgical decompression
101
pre-anesthesia considerations for Chari malformation
Review H&P, deficits, imaging, CBC, BMP, T&C
May hyperventilate to ↓ICP, Lg bore IV x 2 or CVC, Aline
102
classifications of Chiari Malformation
103
Pre-anesthesia considerations for seizures
Determine source of seizures (if known) and how well they are controlled. Want anti-seizure drugs on board before incision.
Review drugs and pharmacokinetic/pharmacodynamic actions
104
May be called to intubate post-seizure
RSI w/cricoid pressure
105
seizure
& causes
transient, paroxysmal, and synchronous discharge of neurons in the brain
caused by transient abnormalities: hypoglycemia, hyponatremia, hyperthermia, intoxication
-In these cases, treating the underlying cause is curative
106
Epilepsy
recurrent seizures d/t congenital or acquired factors
107
Antiepileptic drugs decrease ____ excitability/enhance _____
Antiepileptic drugs decrease **neuronal** excitability/enhance **inhibition**
108
which seizure drugs cause drug-drug interactions
Phenytoin, Tegretol, Barbiturates are enzyme-inducers
109
secondary injuries- TBI (6)
| TBI (traumatic brain injury)
neuroinflammation, cerebral edema, hypoxia, anemia, electrolyte imbalances, neurogenic shock
110
which cranial nerves are commonly affected by myasthenia gravis? what effects do they have?
ocular (common) - diplopia, ptosis
bulbar - laryngeal/pharyngeal weakness leading to respiratory insuffienccy, aspiration risk
111
Myasthenia Gravis Pathophysiology
autoimmune: antibodies generated against N-ACh-receptors at skeletal motor endplate
*no effect on smooth or cardiac muscle
